Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
OPK OPKO Health Q4 2025 EPS outpaces estimates by 42 percent stock ticks higher today BME Blackrock HS management signals focus on highgrowth biotech assets to drive future portfolio returns Is Barrick B stock near resistance Risk Aversion 20260420 Willdan Group WLDN Stock Eyes Breakout 159 20260424 MVST Microvast Holdings Q4 earnings miss of 639 shocks investors as EPS loss of 011 sends stock down 117 Communication Services Select Sector SPDR Fund XLC Mixed Wall Street Sentiment For Top Constituent Comcast CMCSA Signals NearTerm Sector Volatility Why Cohen FOF leadership matters more than you think Smart Money Flows 20260506 Why BlackRock ER BGR business model holds up in any market Momentum Fading 20260508 State Street Utilities Select Sector SPDR ETF XLU Investment Merit Assessment for Defensive Sector Allocation Microsoft Corporation MSFT Delivers Q1 2026 Beat EPS 427 vs 414 Expected Highland HGLB Slides 137 as Selling Pressure Mounts 20260519 Envirotech Vehicles EVTV at 233 Buy Sell or Hold 20260518 Peakstone PKST Q1 2026 Earnings Miss EPS 047 vs 013 Expected Dana Whites Letter to Trump on Gambling Tax Law Shifts Prediction Market Sentiment Sterling Infrastructure STRL Reports Strong Q1 2026 Revenue NA EPS Beats Fed Meeting Minutes Reveal Rate Hike Possibility if Iran Conflict Sustains Inflation Pressures Pliant Therapeutics PLRX Q1 2026 Earnings Beat Revenue NA EPS 032 DLR Q1 2026 Earnings EPS Beats Estimates Amid Data Center Demand Cable One Q1 2026 Earnings EPS Surpasses Estimates Shares Rise 576 PONY Q4 2025 Earnings EPS Beats Estimates Revenue Not Reported Stock Declines DUOT Q1 2026 Earnings Significant EPS Miss Despite Stock Rally Kayne Anderson BDC Inc KBDC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response Lexicon Pharmaceuticals LXRX Slides 31 as Shares Test Key Support Levels Buda Juice Inc BUDA Holds Steady at 876 as Support and Resistance Bounds Tighten Marker Therapeutics MRKR Faces Pressure Stock Slips 21 to 14 Xsolla SPAC 1 Units XSLLU Holds Steady at 998 Amid Consolidation